NO SAFETY CONCERNS OBSERVED WHEN THE ADJUVANTED RECOMBINANT ZOSTER VACCINE (RZV) AND THE COVID-19 MRNA-1273 BOOSTER WERE CO-ADMINISTERED IN ≥50-YEAR-OLDS
| Autor: | Naficy, A., Pirrotta, P., Kuxhausen, A., Miller, J., Leav, B., Mwakingwe-Omari, A. |
|---|---|
| Zdroj: | In International Journal of Infectious Diseases May 2023 130 Supplement 2:S55-S56 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|